LONDON, April 25, 2018 /PRNewswire/ -- The US Food and Drug Administration have accepted an application for a clinical development study on Dronabinol Inhalation using Senzer's unique breath-actuated inhaler, progressing the Company's US partner, INSYS Therapeutics, on its path for...
from PR Newswire: //https://ift.tt/2HVxBql
No comments:
Post a Comment